Europe Blood Collection Devices Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Tubes Type, By Plasma/whole-blood Tubes Type, By Tubes System Type, By Method, By Application, By Country and Growth Forecast, 2021 - 2027
The Europe Blood Collection Devices Market would witness market growth of 5.9% CAGR during the forecast period (2021-2027).
Blood collection has also been recorded to be in high demand because of an expanded number of patients experiencing different ailments connected with kidney, blood, neurological disorders and metabolic diseases. Cancers like lymphoma, leukemia, myeloma, & myelodysplastic syndromes (MDS) may harm the lymph nodes, blood cells, bone marrow, and various other parts of the lymphatic system. It has been seen that apheresis technology has been utilized to decrease the number of white cells until they can be constrained by different drugs.
Various initiatives are taken by the government for in order to improve the regulatory measures & investments in the healthcare and R&D sector are anticipated to contribute in the market growth. This can be attributed to the development of non-invasive techniques that can detect tumor specific aberrations. Also, the use of cellular DNA from plasma is considered as an essential small invasive tool for clinical diagnosis.
As per the information provided by WHO Europe, Europe has around one-eighth of the total population of the world but acquires one quarter of the cancer cases in the world with around 3.7 million new patients every year. A large number of the deaths in the region are caused due to colon, breast, lung, stomach and liver cancer. The number of surgical procedures is also been increasing over the past few years. For example, around 70,230 accident & emergency (A&E) cases were registered in the United Kingdom in 2019.
Additionally, on average the prevalence of iron disease in the region is about 5 to 10 percent. The highest deficiency rate is found in women during the reproductive years. Also, iron deficiency may occur as fatal comorbidity in chronic diseases like renal insufficiency or kidney diseases, intestinal diseases, chronic heart, tumors as well as obesity.
The Germany market dominated the Europe Blood Collection Devices Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $519.7 million by 2027. The UK market is exhibiting a CAGR of 5% during (2021 - 2027). Additionally, The France market would showcase a CAGR of 6.7% during (2021 - 2027).
Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, & Nursing Homes; Diagnostic & Pathology Laboratories, Blood Banks and Others. Based on Product, the market is segmented into Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors and Lancets. Based on Tubes Type, the market is segmented into Plasma/whole-blood Tubes and Serum Tubes. Based on Plasma/whole-blood Tubes Type, the market is segmented into EDTA Tubes, Heparin Tubes, Coagulation Tubes, Glucose Tubes and Others. Based on Tubes System Type, the market is segmented into Vacuum Tubes and Non-Vacuum Tubes. Based on Method, the market is segmented into Manual Blood Collection and Automatic Blood Collection. Based on Application, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sarstedt AG & Company, ICU Medical, Inc., Grifols, S.A., Retractable Technologies, Inc., Quest Diagnostics Incorporated, Becton, Dickinson and Company, Haemonetics Corporation, Terumo Corporation, Fresenius SE & Co. KGaA, and Cardinal Health, Inc.
Scope of the Study
Market Segments covered in the Report:
By End User
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook